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Proliferating cholangiocytes have the capacity to respond and secrete several hor-
mones and neuropeptides, including secretin (Onori et al., 2010). We investigated 
whether secretin secreted by S cells and cholangiocytes increases biliary proliferation 
in mice. Cholestasis was induced in secretin knockout (Sct-/-) and wild-type (control) 
mice by bile duct ligation (BDL) (Glaser et al., 2009). After 7 days of BDL, control 
and Sct-/- mice received tail-vein injections of morpholinos against microRNA 125b or 
let7a. One week later, liver tissues and cholangiocytes were collected and immuno-
histochemical, immunoblot, and real-time polymerase chain reaction assays were per-
formed. Intrahepatic bile duct mass (IBDM) and proliferation were evaluated. Secre-
tin secretion was measured in conditioned media from cholangiocytes and S cells. 
Secretin secretion was increased in supernatants from cholangiocytes and S cells after 
BDL in control mice. BDL Sct-/- mice had lower IBDM, reduced proliferation, and 
reduced production of VEGF and NGF compared with BDL control. BDL and con-
trol mice given morpholinos against microRNA 125b or let7a had increased IBDM, 
expression of VEGFA and NGF. Secretin regulated VEGF and NGF expression that 
negatively correlated with microRNA 125b and let7a levels in liver tissue. After liver 
injury, secretin produced by cholangiocytes and S cells reduces microRNA 125b and 
let7a levels, resulting in up-regulation of VEGF and NGF. Modulation of cholangio-
cyte expression of secretin could be a therapeutic approach for biliary diseases.
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